Cargando…

Tumour necrosis factor-dependent inflammatory cartilage destruction

Detalles Bibliográficos
Autores principales:	Korb, A, Tuerk, B, Echtermeyer, F, Pap, T, Smolen, JS, Redlich, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061930/ http://dx.doi.org/10.1186/ar2230

Ejemplares similares

Inhibition of Syndecan-4 by therapeutic antibodies reduces TNFα dependent joint destruction in mice
por: Stratis, Athanasios, et al.
Publicado: (2012)

Matrix remodeling during enchondral ossification and aggrecan cleavage in osteoarthritic cartilage depends on syndecan-4
por: Echtermeyer, Frank, et al.
Publicado: (2007)

Tumor necrosis factor alpha downregulates bone morphogenetic protein expression and matrix macromolecule synthesis in articular cartilage
por: Bobacz, K, et al.
Publicado: (2004)

Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis
por: Wäldele, Stefan, et al.
Publicado: (2015)

Direct analysis of bone turnover in experimental arthritis
por: Polzer, K, et al.
Publicado: (2005)

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

Repair of local bone erosions by combined treatment with parathyroid hormone, osteoprotegerin and anti-tumor necrosis factor in tumor necrosis factor-transgenic mice
por: Redlich, K, et al.
Publicado: (2003)

Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis
por: Zwerina, Jochen, et al.
Publicado: (2006)

IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
por: Abdollahi-Roodsaz, S, et al.
Publicado: (2005)

Heme oxygenase 1 regulates osteoclastogenesis
por: Zwerina, J, et al.
Publicado: (2005)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Schett, G, et al.
Publicado: (2003)

Laminin, but not lipopolysaccharide, IL-1 or tumor necrosis factor alpha, induces IL-16 gene activity in synovial fibroblasts
por: Aicher, W, et al.
Publicado: (2003)

Cartilage-derived morphogenetic protein-1 and cartilage-derived morphogenetic protein-2 are present in ligament fibroblasts and lead to chondrogenic differentiation
por: Bobacz, K, et al.
Publicado: (2003)

Living with Tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS)
por: Dandekar, P, et al.
Publicado: (2015)

Resistance of rheumatoid arthritis synovial fibroblasts to p38 MAP-kinase inhibition of pro-destructive functions mediated by tumor necrosis factor alpha/tumor necrosis factor receptor-1
por: Kunisch, E, et al.
Publicado: (2005)

Opioid receptor expression on neutrophils: effect of tumour necrosis factor alpha treatment
por: Schmidt, A, et al.
Publicado: (2007)

The bacterial effector protein YopM reduces rheumatoid arthritis (RA) outcome by inhibiting inflammation and bone destruction
por: Bertrand, J, et al.
Publicado: (2012)

Smad-dependent mechanisms of inflammatory bone destruction
por: Fennen, Michelle, et al.
Publicado: (2016)

Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation
por: Görtz, B, et al.
Publicado: (2004)

Floating anchorage-independent fibroblast-like cells mediate cartilage destruction independently from the hyperplastic synovial tissue
por: Neidhart, M, et al.
Publicado: (2003)

AJAK inhibitor, tofacitinibreduces IL-6 and matrix metalloproteinase-3 productionin rheumatoid arthritis with suppressed cartilage destruction
por: Yamaoka, Kunihiro, et al.
Publicado: (2012)

Paracrine pathways of cartilage destruction in osteoarthritis
por: Abramson, S, et al.
Publicado: (2003)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy
por: Russo, R, et al.
Publicado: (2011)

Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
por: Cavazzana, I, et al.
Publicado: (2005)

Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy
por: Radziszewska, Anna, et al.
Publicado: (2014)

Combined depletion of interleukin-1 and interleukin-6 does not exceed single depletion of interleukin -1 in TNF-mediated arthritis
por: Hayer, Silvia, et al.
Publicado: (2012)

Quantitative and qualitative analysis of CD4(+)CD25(+ )regulatory T cells in systemic lupus erythematosus patients
por: Bonelli, M, et al.
Publicado: (2005)

Transfer of protease inhibitors to inhibit cartilage destruction
por: van der Laan, WH, et al.
Publicado: (2001)

Microarray analysis for molecular characterization of disease activity and measuring outcomes of anti-tumour necrosis factor therapy in rheumatoid arthritis
por: Stuhlmüller, B, et al.
Publicado: (2005)

How does tumour necrosis factor uncouple T-cell receptor-induced IL-2 gene expression in murine T cells?
por: Clark, JM, et al.
Publicado: (2005)

Therapeutic inhibition of tumour necrosis factor alpha reduces oligoclonality in the selected T-cell receptor BV families in rheumatoid arthritis
por: Pierer, M, et al.
Publicado: (2003)

Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis
por: Ramirez, J, et al.
Publicado: (2010)

Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2005)

Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis
por: Schmeling, H, et al.
Publicado: (2008)

Long-term exposure of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha inhibits FasL-mediated apoptosis through activation of NF-κB and upregulation of the small ubiquitin-like modifier SUMO-1
por: Pap, T, et al.
Publicado: (2004)

Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
por: Coulthard, LR, et al.
Publicado: (2007)

Different molecules at the surface of stimulated T cells induce IL-1beta, tumour necrosis factor and IL-1RA in human monocytes
por: Burger, D, et al.
Publicado: (2005)

Stat1 and phosphorylated Stat1 are increased in lymphocytes and monocytes of patients with systemic lupus erythematosus
por: Aringer, M, et al.
Publicado: (2005)

Inhibition of tumour necrosis factor alpha production by activated T cells of rheumatoid arthritis patients by novel anti-folate drugs: an ex vivo pilot study
por: van der Heijden, JW, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_qi55lnbrq3ugm9vm1fevcajjhf